RESEARCH-USE BIOSIMILAR ANTIBODY

Erzotabart

Monoclonal antibody · IgG1

CD38IgG1RUO

Erzotabart is an IgG1-kappa, anti-CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) Homo sapiens monoclonal antibody. Erzotabart shows antineoplastic activity.

TARGETCD38
YMonoclonal antibody
CATALOGSC-BS-565
CATALOG NUMBERSC-BS-565
MOLECULAR WEIGHTApprox. 145.056 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Erzotabart is an IgG1-kappa, anti-CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) Homo sapiens monoclonal antibody. Erzotabart shows antineoplastic activity.

Erzotabart is a recombinant research-use antibody directed against CD38.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Erzotabart | StellaCyte